Copyright Reports & Markets. All rights reserved.

Global Brain Aneurysm Market Insights, Forecast to 2025

Request for Sample of this report
Buy now
  • 1.1 Research Scope
  • 1.2 Market Segmentation
  • 1.3 Research Objectives
  • 1.4 Research Methodology
    • 1.4.1 Research Process
    • 1.4.2 Data Triangulation
    • 1.4.3 Research Approach
    • 1.4.4 Base Year
  • 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
    • 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.5.2 Covid-19 Impact: Commodity Prices Indices
    • 1.5.3 Covid-19 Impact: Global Major Government Policy
  • 1.6 The Covid-19 Impact on Brain Aneurysm Industry
  • 1.7 COVID-19 Impact: Brain Aneurysm Market Trends

    • 2 Global Brain Aneurysm Quarterly Market Size Analysis

    • 2.1 Brain Aneurysm Business Impact Assessment - COVID-19
      • 2.1.1 Global Brain Aneurysm Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
    • 2.2 Global Brain Aneurysm Quarterly Market Size 2020-2021
    • 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
      • 2.3.1 Drivers
      • 2.3.2 Restraints
      • 2.3.3 Opportunities
      • 2.3.4 Challenges

    3 Quarterly Competitive Assessment, 2020

    • 3.1 By Players, Global Brain Aneurysm Quarterly Market Size, 2019 VS 2020
    • 3.2 By Players, Brain Aneurysm Headquarters and Area Served
    • 3.3 Date of Key Players Enter into Brain Aneurysm Market
    • 3.4 Key Players Brain Aneurysm Product Offered
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Impact of Covid-19 on Brain Aneurysm Segments, By Type

    • 4.1 Introduction
      • 1.4.1 Surgical clipping
      • 1.4.2 Endovascular coiling
      • 1.4.3 Flow diverter
      • 1.4.4 Other
    • 4.2 By Type, Global Brain Aneurysm Market Size, 2019-2021

    5 Impact of Covid-19 on Brain Aneurysm Segments, By Application

    • 5.1 Overview
      • 5.5.1 Hospital
      • 5.5.2 Clinics
      • 5.5.3 Other
    • 5.2 By Application, Global Brain Aneurysm Market Size, 2019-2021
      • 5.2.1 By Application, Global Brain Aneurysm Market Size by Application, 2019-2021

    6 Geographic Analysis

    • 6.1 Introduction
    • 6.2 North America
      • 6.2.1 Macroeconomic Indicators of US
      • 6.2.2 US
      • 6.2.3 Canada
    • 6.3 Europe
      • 6.3.1 Macroeconomic Indicators of Europe
      • 6.3.2 Germany
      • 6.3.3 France
      • 6.3.4 UK
      • 6.3.5 Italy
    • 6.4 Asia-Pacific
      • 6.4.1 Macroeconomic Indicators of Asia-Pacific
      • 6.4.2 China
      • 6.4.3 Japan
      • 6.4.4 South Korea
      • 6.4.5 India
      • 6.4.6 ASEAN
    • 6.5 Rest of World
      • 6.5.1 Latin America
      • 6.5.2 Middle East and Africa

    7 Company Profiles

    • 7.1 Medtronic
      • 7.1.1 Medtronic Business Overview
      • 7.1.2 Medtronic Brain Aneurysm Quarterly Revenue, 2020
      • 7.1.3 Medtronic Brain Aneurysm Product Introduction
      • 7.1.4 Medtronic Response to COVID-19 and Related Developments
    • 7.2 Codman & Shurtleff
      • 7.2.1 Codman & Shurtleff Business Overview
      • 7.2.2 Codman & Shurtleff Brain Aneurysm Quarterly Revenue, 2020
      • 7.2.3 Codman & Shurtleff Brain Aneurysm Product Introduction
      • 7.2.4 Codman & Shurtleff Response to COVID-19 and Related Developments
    • 7.3 Raumedic
      • 7.3.1 Raumedic Business Overview
      • 7.3.2 Raumedic Brain Aneurysm Quarterly Revenue, 2020
      • 7.3.3 Raumedic Brain Aneurysm Product Introduction
      • 7.3.4 Raumedic Response to COVID-19 and Related Developments
    • 7.4 Vittamed
      • 7.4.1 Vittamed Business Overview
      • 7.4.2 Vittamed Brain Aneurysm Quarterly Revenue, 2020
      • 7.4.3 Vittamed Brain Aneurysm Product Introduction
      • 7.4.4 Vittamed Response to COVID-19 and Related Developments
    • 7.5 Sophysa
      • 7.5.1 Sophysa Business Overview
      • 7.5.2 Sophysa Brain Aneurysm Quarterly Revenue, 2020
      • 7.5.3 Sophysa Brain Aneurysm Product Introduction
      • 7.5.4 Sophysa Response to COVID-19 and Related Developments
    • 7.6 MicroPort Scientific
      • 7.6.1 MicroPort Scientific Business Overview
      • 7.6.2 MicroPort Scientific Brain Aneurysm Quarterly Revenue, 2020
      • 7.6.3 MicroPort Scientific Brain Aneurysm Product Introduction
      • 7.6.4 MicroPort Scientific Response to COVID-19 and Related Developments
    • 7.7 Orsan Medical
      • 7.7.1 Orsan Medical Business Overview
      • 7.7.2 Orsan Medical Brain Aneurysm Quarterly Revenue, 2020
      • 7.7.3 Orsan Medical Brain Aneurysm Product Introduction
      • 7.7.4 Orsan Medical Response to COVID-19 and Related Developments
    • 7.8 Spiegelberg
      • 7.8.1 Spiegelberg Business Overview
      • 7.8.2 Spiegelberg Brain Aneurysm Quarterly Revenue, 2020
      • 7.8.3 Spiegelberg Brain Aneurysm Product Introduction
      • 7.8.4 Spiegelberg Response to COVID-19 and Related Developments
    • 7.9 Johnson & Johnson
      • 7.9.1 Johnson & Johnson Business Overview
      • 7.9.2 Johnson & Johnson Brain Aneurysm Quarterly Revenue, 2020
      • 7.9.3 Johnson & Johnson Brain Aneurysm Product Introduction
      • 7.9.4 Johnson & Johnson Response to COVID-19 and Related Developments
    • 7.10 Sophysa
      • 7.10.1 Sophysa Business Overview
      • 7.10.2 Sophysa Brain Aneurysm Quarterly Revenue, 2020
      • 7.10.3 Sophysa Brain Aneurysm Product Introduction
      • 7.10.4 Sophysa Response to COVID-19 and Related Developments
    • 7.11 HaiWeiKang
      • 7.11.1 HaiWeiKang Business Overview
      • 7.11.2 HaiWeiKang Brain Aneurysm Quarterly Revenue, 2020
      • 7.11.3 HaiWeiKang Brain Aneurysm Product Introduction
      • 7.11.4 HaiWeiKang Response to COVID-19 and Related Developments
    • 7.12 Head Sense Medical
      • 7.12.1 Head Sense Medical Business Overview
      • 7.12.2 Head Sense Medical Brain Aneurysm Quarterly Revenue, 2020
      • 7.12.3 Head Sense Medical Brain Aneurysm Product Introduction
      • 7.12.4 Head Sense Medical Response to COVID-19 and Related Developments
    • 7.13 InfraScan
      • 7.13.1 InfraScan Business Overview
      • 7.13.2 InfraScan Brain Aneurysm Quarterly Revenue, 2020
      • 7.13.3 InfraScan Brain Aneurysm Product Introduction
      • 7.13.4 InfraScan Response to COVID-19 and Related Developments
    • 7.14 Integra Life Sciences
      • 7.14.1 Integra Life Sciences Business Overview
      • 7.14.2 Integra Life Sciences Brain Aneurysm Quarterly Revenue, 2020
      • 7.14.3 Integra Life Sciences Brain Aneurysm Product Introduction
      • 7.14.4 Integra Life Sciences Response to COVID-19 and Related Developments

    8 Key Findings

      9 Appendix

      • 9.1 About US

      This report covers market size and forecasts of Brain Aneurysm, including the following market information:
      Global Brain Aneurysm Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
      Global Brain Aneurysm Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
      Global Brain Aneurysm Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
      Global Brain Aneurysm Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)

      Key market players
      Major competitors identified in this market include Medtronic, Codman & Shurtleff, Raumedic, Vittamed, Sophysa, MicroPort Scientific, Orsan Medical, Spiegelberg, Johnson & Johnson, Sophysa, HaiWeiKang, Head Sense Medical, InfraScan, Integra Life Sciences, etc.

      Based on the Region:
      Asia-Pacific (China, Japan, South Korea, India and ASEAN)
      North America (US and Canada)
      Europe (Germany, France, UK and Italy)
      Rest of World (Latin America, Middle East & Africa)

      Based on the Type:
      Surgical clipping
      Endovascular coiling
      Flow diverter
      Other

      Based on the Application:
      Hospital
      Clinics
      Other

      Buy now